SCHEMBL606385

SCHEMBL606385

C1CN[C@@H]2CNC[C@@H]2C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL606391 1.00
SCHEMBL7496575 1.00
SCHEMBL1726593 1.00
SCHEMBL7496569 1.00
SCHEMBL64396 1.00
SCHEMBL1723503 1.00
SCHEMBL1724943 1.00
SCHEMBL29208889 1.00
Hydrochloric Acid SCHEMBL3332500 0.98 CCR5 (0.36)
SCHEMBL8704625 0.93 EPAS1 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 291 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022166440-A1 METHOD FOR PREPARING MOXIFLOXACIN INTERMEDIATE, (S,S)-2,8-DIAZABICYCLO[4,3,0]NONANE 台州市生物医化产业研究院有限公司 2022-08-11 WO claimed
WO-2022166436-A1 METHOD FOR PREPARING MOXIFLOXACIN INTERMEDIATE (S, S)-2, 8-DIAZABICYCLO [4, 3, 0] NONANE 台州市生物医化产业研究院有限公司 2022-08-11 WO claimed
CN-107686852-B Preparation method of moxifloxacin intermediate compound 上海朴颐化学科技有限公司 2022-08-02 CN claimed
CN-113321652-A Boron removing method of moxifloxacin hydrochloride and preparation method of moxifloxacin hydrochloride pure product 山东鲁抗医药股份有限公司 2021-08-31 CN claimed
EP-2403831-B1 SYNTHESIS OF (4aS,7aS)-OCTAHYDRO-1H-PYRROLOÝ3,4-b¨PYRIDINE ITALIANA SINT SPA (IT) 2015-05-20 EP claimed
EP-2423211-B1 PROCESSES FOR PRODUCING (1S,6S)- OR (1R,6R)-CIS-2,8-DIAZABICYCLO[4.3.0]NONANE AND INTERMEDIATE THEREOF KANEKA CORP (JP) 2014-04-16 EP claimed
EP-2089388-B1 PROCESS FOR THE SYNTHESIS OF MOXIFLOXACIN HYDROCHLORIDE CIPLA LTD (IN) 2014-01-29 EP claimed
US-8497377-B2 Process for preparing pradofloxacin BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-07-30 US claimed
US-8198451-B2 Process for the synthesis of moxifloxacin hydrochloride CIPLA LIMITED (IN) 2012-06-12 US claimed
EP-2423211-A1 PROCESSES FOR PRODUCING (1S,6S)- OR (1R,6R)-CIS-2,8-DIAZABICYCLO[4.3.0]NONANE AND INTERMEDIATE THEREOF Kaneka Corporation (JP) 2012-02-29 EP claimed
US-6995170-B1 Semi-hydrochloride of 8-cyano-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1, 4-dihydro-4-oxo-3-quinolinecarboxylic acid BAYER AKTIENGESELLSCHAFT (DE) 2006-02-07 US claimed
EP-1077979-B1 METHOD FOR PRODUCING (S,S)-BENZYL-2,8-DIAZABICYCLO 4.3.0]NONANE BAYER HEALTHCARE AG (DE) 2005-07-06 EP claimed
EP-1133497-B1 CRYSTAL MODIFICATION B OF 8-CYANO-1- CYCLOPROPYL -7-(1S,6S-2, 8-DIAZABICYCLO 4.3.0]NONAN -8-YL)-6- FLUORO-1,4- DIHYDRO-4- OXO-3-QUINOLINE CARBOXYLIC ACID BAYER HEALTHCARE AG (DE) 2005-02-23 EP claimed
US-20040044205-A1 Process for the enantiomeric enrichment of cis-8-benzyl-7,9-dioxo-2,8-diazabicyclo[4.3.0]nonane LANXESS DEUTSCHLAND GMBH (DE) 2004-03-04 US claimed
EP-1375501-A1 Process for enantiomeric enrichment of cis-8-benzyl-7,9-dioxo-2,8-diazabicyclo(4.3.0)nonane using simulated moving bed chromatography Bayer Chemicals AG (DE) 2004-01-02 EP claimed
US-6664268-B1 Easy to handle; reduced water vapor absorption BAYER AKTIENGESELLSCHAFT (DE) 2003-12-16 US claimed
EP-1133495-B1 SEMI-HYDROCHLORIDE OF 8-CYAN-1- CYCLOPROPYL -7-(1S,6S-2 ,8-DIAZABICYCLO 4.3.0]NONAN -8-YL)-6- FLUORO-1, 4-DIHYDRO -4-OXO-3- QUINOLINE CARBOXYLIC ACID BAYER AG (DE) 2002-10-09 EP claimed
US-6235908-B1 PREPARATION OF TARTRATE BAYER AKTIENGESELLSCHAFT (DE) 2001-05-22 US claimed
EP-1077979-A1 METHOD FOR PRODUCING (S,S)-BENZYL-2,8-DIAZABICYCLO 4.3.0]NONANE BAYER AG (DE) 2001-02-28 EP claimed
WO-1999058532-A1 METHOD FOR PRODUCING (S,S)-BENZYL-2,8-DIAZABICYCLO[4.3.0]NONANE BAYER AKTIENGESELLSCHAFT (DE) 1999-11-18 WO claimed